Using MAP technology, we are building functional tissue and organs within patients to treat disease. Our mission is to use MAP technology to harness the power of immunomodulation and material science to transform the landscape of medical technology, enabling the future of medicine.

Tempo’s leading biosurgery products solve significant clinical challenges in patients undergoing soft tissue reconstructions for dermal and abdominal wall indications. By building new vascular tissue in these patients, our products improve tissue strength and restore function – improving outcomes and saving lives. Using the MAP core technology, Tempo is also developing combination drug delivery, allogenic cell engraftment, and next-generation vaccine technologies.

Tempo is developing novel therapies based on MAP technology in many therapeutic areas. We are actively engaged in building strategic relationships to bolster current development and access new therapeutic areas – with the goal of using tissue engineering to build better lives for patients in need.